What Are the Most Common Budgeting Mistakes in Non-Commercial Clinical Trials?

What Are the Most Common Budgeting Mistakes in Non-Commercial Clinical Trials?

Non-commercial clinical trials, most often conducted by universities, hospitals, research institutes, or foundations, play an important role in advancing medicine and generating new scientific knowledge. At the same time, preparing their budgets can be a major challenge, as organizations initiating these projects often have less experience in estimating the full costs of conducting a clinical trial.

One of the most common mistakes is underestimating the overall scope of work required to conduct the trial. Budgets often include only direct costs, such as diagnostic tests or medical supplies, while overlooking the costs of project management, monitoring, data management, statistical analysis, documentation preparation, and regulatory support.

Another frequent issue is inaccurate estimation of project team costs. Non-commercial clinical trials require the involvement of many specialists, including project managers, clinical research associates, statisticians, data managers, safety specialists, medical experts, and staff responsible for documentation. Failing to account for these resources can lead to difficulties in carrying out the project.

Another common mistake is the lack of an adequate financial contingency for potential risks. During a trial, unforeseen situations may arise, such as slower patient recruitment, the need to increase the number of sites, additional regulatory activities, or changes to study documentation. A budget that does not account for such scenarios may prove insufficient.

Non-commercial clinical trials also often overlook costs related to quality and regulatory compliance. Regardless of the source of funding, the trial must comply with Good Clinical Practice (ICH GCP) requirements, and documentation must be prepared and maintained in accordance with applicable standards.

Another important challenge is improper planning of the funding schedule. Delays in the transfer of funds can make it difficult to carry out activities on time, particularly payments to research sites, vendors, and members of the study team.

A properly prepared budget for a non-commercial clinical trial should cover all stages of the project – from documentation preparation and obtaining approvals, through trial conduct and data analysis, to preparation of final reports and document archiving. Realistic cost planning increases the chances of completing the project on time and reduces the risk of premature termination due to financial constraints.

Other questions: Budget and research financing

See also

How to Prepare a Budget for a Multicenter Clinical Trial? How to Prepare a Budget for a Multicenter Clinical Trial?
Przygotowanie budżetu badania wieloośrodkowego jest jednym z kluczowych etapów planowania projektu klinicznego. Odpowiednio opracowany budżet pozwala realnie...
What Elements Should Be Included in a Financial Appendix to an Agreement with a Research Site? What Elements Should Be Included in a Financial Appendix to an Agreement with a Research Site?
The financial appendix to an agreement with a research site is one of the key documents governing cooperation in a clinical trial. It defines the remuneratio...
Clinical Trial Payments: Who Pays Whom and for What? Clinical Trial Payments: Who Pays Whom and for What?
Financial arrangements in clinical trials depend on the organizational model of the p...
Copyright© 2023 Biostat